Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence - Wikidata - awgldk - TriplyDB

Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence

Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence

http://www.wikidata.org/entity/Q42127740

about

Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy The Mu subunit of Plasmodium falciparum clathrin-associated adaptor protein 2 modulates in vitro parasite response to artemisinin and quinine Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.Contribution of Plasmodium knowlesi to Multispecies Human Malaria Infections in North Sumatera, Indonesia.A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species.High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.Plasmodium yoelii vitamin B5 pantothenate transporter candidate is essential for parasite transmission to the mosquito.Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT.Antimalarial activity of the myxobacterial macrolide chlorotonil a.Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam Effect of fluorescent dyes on in vitro-differentiated, late-stage Plasmodium falciparum gametocytes.Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.High levels of asymptomatic and subpatent Plasmodium falciparum parasite carriage at health facilities in an area of heterogeneous malaria transmission intensity in the Kenyan highlands.Novel genotyping tools for investigating transmission dynamics of Plasmodium falciparum Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian Amazon Dynamical malaria models reveal how immunity buffers effect of climate variability.Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children A deep sequencing tool for partitioning clearance rates following antimalarial treatment in polyclonal infections.Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.Persistence of Plasmodium falciparum parasitemia after artemisinin combination therapy: evidence from a randomized trial in Uganda No Clinical or Molecular Evidence of Plasmodium falciparum Resistance to Artesunate-Mefloquine in Northwestern Brazil.Assessment of submicroscopic infections and gametocyte carriage of Plasmodium falciparum during peak malaria transmission season in a community-based cross-sectional survey in western Kenya, 2012.Characterizing microscopic and submicroscopic malaria parasitaemia at three sites with varied transmission intensity in Uganda.Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers.Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross-sectional study in southern Malawi.Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Naturally acquired immunity to sexual stage P. falciparum parasites.Focal Screening to Identify the Subpatent Parasite Reservoir in an Area of Low and Heterogeneous Transmission in the Kenya Highlands.Sustained Ex Vivo Susceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia.Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence.

P2860

Q26209187-30E93C51-634F-4149-937C-F3D466F2D3D0 Q27974348-6227D1A7-1329-4955-AB21-F4107D09847F Q30240158-75D68DCC-C0DA-4A39-9668-C2007D341082 Q33662235-FDA7D00B-01FC-4781-9B6E-E8019D607326 Q33703317-0F635164-3556-4920-958A-B4122DF67776 Q33729200-72BA8A1B-EE60-4CFE-AFED-90F8DA65AC88 Q33883363-35F59314-FB16-4D6D-A3AF-D5C313F9D785 Q33901814-88E483FD-0753-4529-A363-EB04AD1A5F65 Q34020818-FC0AA935-7E35-46C5-8D50-FFB2BC44829C Q34563560-6AE76E34-F558-443C-98A6-06BC8506017E Q34596488-8C71B1AF-C0A8-4EFC-A474-605315E6D113 Q34597617-DC222814-301E-42EF-9391-7A04518803E6 Q34597823-A078C205-BD28-4558-906A-4C3F9AD1DB37 Q34629332-CB1F1272-D0BC-4729-A689-83E1B15A03E9 Q34640098-71FF90AF-1F07-4334-A6F1-28D5668C51E7 Q34736521-4160F028-7FF4-4E16-8788-EB2A5050FE84 Q35068667-9DD9163B-A853-419F-A075-EF88A250FF3C Q35102694-1507ECB0-82EA-4AB0-8C63-D924CB5B772A Q35473530-F552F548-5FF1-4017-971A-EF116C4028E5 Q35865734-5AF68917-9A86-46E7-9FFC-862CF749D948 Q35975609-FC39E54F-FF7D-48AE-B46D-DA7ADE83D3E5 Q35991544-EAABCAE4-2203-4AD2-8556-27B44B75897E Q36076111-76075B53-8E00-4077-8762-9D9A7209F9B0 Q36489713-DCC3E86E-E8F5-4533-9B0E-1687B98A3205 Q36579251-A5123438-5E66-4EC3-9EA5-8F1054C2B6C2 Q36689509-70DF1E9F-6973-418E-B52F-947ABEE44424 Q36919292-9E40EEAC-ECC1-4D1E-8793-006F47899DDF Q37094424-6E4DA81A-83D8-4387-B011-FC31C805EE38 Q37192206-C63825B4-D061-40A4-8B76-A562264E94C5 Q37258158-0F485ADF-88E4-40BB-A8C8-0A7EB85B0300 Q37357025-938BE1C8-6037-4DE2-872F-ACE1EA9EB8CC Q37358872-D3B98E52-37EF-4F52-8964-E9FBD32CF1B4 Q37394779-B16FE522-1121-4174-9E54-A378C8D804C3 Q37497492-881981C9-5955-490E-9AF2-B338833566C1 Q37576425-03093C3B-4611-4A48-B67D-259FE59EB943 Q38529669-5AD8F380-2267-428C-92BC-79A5B80D9AB8 Q38689928-65E2BF7F-10BC-4112-8BF8-E6726FC9DD11 Q39493802-F5E7AF74-88D1-41A2-BF7E-83F6733B98A6 Q41911850-39D3BD19-68DF-4CC7-8D08-23B540EE3CA5 Q43923927-5D7E5519-B2B4-46CD-B9CB-03A847942B1C

P2860

Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence

http://www.wikidata.org/entity/Q42127740

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Residual Plasmodium falciparum ...... uitoes and parasite recurrence

@en

Residual Plasmodium falciparum ...... uitoes and parasite recurrence

@nl

type

label

Residual Plasmodium falciparum ...... uitoes and parasite recurrence

@en

Residual Plasmodium falciparum ...... uitoes and parasite recurrence

@nl

prefLabel

Residual Plasmodium falciparum ...... uitoes and parasite recurrence

@en

Residual Plasmodium falciparum ...... uitoes and parasite recurrence

@nl

P1433

Q42127740-086D35B8-BA64-43B8-B17F-FB6B65C11D15

P1476

Q42127740-DD96DCA6-4A5F-4781-B5E5-62A22A59C22F

P2093

Q42127740-19DFB911-AFAC-4B13-9D86-F34CBC27873C

Q42127740-2575DCF7-1532-4AC4-B1D0-581D47ABD424

Q42127740-2DAB45C5-076D-44F5-84F1-1E6057676D3D

Q42127740-31BED892-CEC0-4FCD-8B2E-AF4C2C21E154

Q42127740-82FDBB56-912D-4D8E-A0F9-8703BCE54424

Q42127740-8F1F6286-2B6F-45EC-B97A-6797BEF02262

Q42127740-BE3EBD0A-6BA5-4288-B42A-98C21E75EFC9

Q42127740-DF0EBCA4-C667-49F8-B585-D791897E58EA

Q42127740-E858CCCE-DDD6-410F-B56C-45666B8E311B

P2860

Q42127740-130D7604-6CA4-4F0F-860C-CD76792832B3

Q42127740-146EE6C0-E5E3-4739-A797-6C76CBFF0CDE

Q42127740-1BEB7537-C71C-46F4-99C4-65564B5EB556

Q42127740-1C803D72-14A0-4339-8231-4CBA3AF1E6F1

Q42127740-1DE26CBA-E3DC-4035-BDA0-21E6A1DC7B4E

Q42127740-1F8162CE-A41B-4776-AB56-E82526CF3A18

Q42127740-20E8C289-E121-4FA3-AA00-60F8CD1DED1F

Q42127740-28F686D2-95BD-421D-B017-3F572B80C63F

Q42127740-31ADB263-63AF-4326-8A43-C648DEEFAFBF

Q42127740-3494AAA2-20D7-4045-9679-22BCD710CC9B

P304

Q42127740-D78EFD50-B1B2-4215-B1D3-54AE74602AAA

P31

Q42127740-FCCE84BC-3EB2-4764-B6F0-F3298BAD5CB2

P356

Q42127740-78FD580E-BE32-4706-BB41-512EF072B6E1

P407

Q42127740-88613BF7-8316-46F1-B5F9-13114C82D830

P433

Q42127740-57CAD01A-01D4-43A4-B81B-F73FB9E4B0CE

P478

Q42127740-E89A3894-077F-4C7E-96C4-519D9CB7C25D

P50

Q42127740-23928DE6-BB4D-4793-B7ED-DED3DD8E8E50

Q42127740-3440F76F-E3EE-42FC-AA4F-78FF875C1E4C

Q42127740-42C7B528-7F17-46F4-9D29-1624015A3AFB

Q42127740-6FCC4AD3-1C02-464D-B15E-279E510A7157

Q42127740-B3496619-D2D0-405A-B9E5-28E5B7A4F021

Q42127740-E251936D-C49D-4070-89E5-7EFF0FFC8962

P577

Q42127740-879A754A-DA31-4D1B-A1DF-9BAA7803FA08

P5875

Q42127740-E7ED5F16-5E19-49EF-B04F-E0F7DD3D4361

P698

Q42127740-75D91CBB-BB76-42C3-98B2-FAFD20A24227

P921

Q42127740-35F25479-8D69-4C3B-9515-FDA31C947A7D

Q42127740-6B472094-75F5-4EC8-985D-0EA12544111C

Q42127740-962E1801-4694-46A3-99A4-63ACB25C07B3

P932

Q42127740-CE6F4BB7-3B7B-4FE1-838B-4680D9E4A613

P356

P1433

The Journal of Infectious Diseases

P1476

Residual Plasmodium falciparum ...... uitoes and parasite recurrence

@en

P2093

Arnold Ndaro

http://www.w3.org/2001/XMLSchema#string

Collins K Mweresa

http://www.w3.org/2001/XMLSchema#string

Harparkash Kaur

http://www.w3.org/2001/XMLSchema#string

Henk D F H Schallig

http://www.w3.org/2001/XMLSchema#string

Jaffu Chilongola

http://www.w3.org/2001/XMLSchema#string

Patrick Sawa

http://www.w3.org/2001/XMLSchema#string

Rachel L Hallett

http://www.w3.org/2001/XMLSchema#string

Sabah A Omar

http://www.w3.org/2001/XMLSchema#string

Seif A Shekalaghe

http://www.w3.org/2001/XMLSchema#string

P2860

Qinghaosu (Artemisinin): The Price of Success

Artemisinin-resistant malaria: research challenges, opportunities, and public health implications

Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border

Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment

Artemisinin Resistance in Plasmodium falciparum Malaria

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

The perils of PCR: can we accurately 'correct' antimalarial trials?

Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

P304

2017-2024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIT431

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

208

http://www.w3.org/2001/XMLSchema#string

P50

Colin J Sutherland

Chris J Drakeley

Khalid B Beshir

Robert W Sauerwein

P577

2013-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255954686

http://www.w3.org/2001/XMLSchema#string

P698

23945376

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

3836468

http://www.w3.org/2001/XMLSchema#string